SEC Form D filing

Biosceptre International Ltd, 2026-07-28

An SEC Form D private-offering notice from Cambridge, a $345,981 filer-stated offering target in Biotech. Filed 2026-07-28. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Biosceptre International Ltd site↗ Verified via SEC Form D

Cambridge, UK biopharmaceutical company developing CAR T and antibody based cancer therapies targeting nfP2X7

Filed 2026-07-28Filed to raise $345,981First money in 2026-06-25Raised so far $345,981HQ (as filed) CambridgeSector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified biosceptre.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source